Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oh, William K."'
Autor:
Rettig MB; Prostate Cancer Program, Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, California., Beltran H; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Oh WK; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 May; Vol. 20 Suppl 9 (5), pp. 1-20.
Autor:
Oh WK; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 May; Vol. 20 Suppl 9 (5), pp. 13-16.
Autor:
Oh WK; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Rettig MB; Prostate Cancer Program, Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, California.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 May; Vol. 20 Suppl 9 (5), pp. 16-17.
Autor:
Michaelson MD; Massachusetts General Hospital, Dana-Farber Cancer Institute, Boston, MA, USA. dmichaelson1@partners.org, Kaufman DS, Oh WK
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2003 Feb; Vol. 1 (2), pp. 102-4; discussion 105.